Therapeutic Delivery – News and Features
News
Rexahn, University Partner for Drug Development
Researchers hope nanomedicine can lead to advances in "targeted delivery".
News
Nastech Acquires RNAi Therapeutics Program from Galenea
Nastech will initiate an RNAi therapeutics program targeting influenza and respiratory diseases.
News
RheoGene Grants Ichor License to Develop a Regulated Gene Therapy
Ichor has granted an option for RheoGene to license Ichor’s TriGrid™ Delivery System to develop proprietary therapeutics.
News
UCLA Researcher Developing Lab to Help Manufacturer Testing
UCLA team has developed a testing method to assess the safety and health risks of engineered nanomaterials.
News
Nanotrope Awarded NASA Phase 2 Grant
Nanotrope has been awarded this grant to Advance Nanoscale Drug Delivery.
News
NanoDynamics Taps Chemists for ND Life Sciences Operation
Drs. Sang Beom Lee and Lacramioara Trofin to drive new product innovation for biotech and healthcare.
News
Cascade Gets Award for Microfluidics Metrology System
Cascade Microtech honored with an Electronic Products' Product of the Year award.
News
Viral, Gold Nanoparticles Can Assemble Themselves to Find and Treat Disease
The study defines how assembled particles of gold could possibly be "tuned" to destroy tissue.
News
Nanomedicine Center to Help Develop Cancer and CNS Therapies
The University of Maryland and Rexahn Pharmaceuticals are working together to help develop cancer-fighting drugs and central nervous system therapies.
News
Avantium and WEP Collaborate to Develop POLY PEG® Technology
POLY PEG® technology has been developed to increase the bioavailability of drug molecules.
Advertisement
